Filing Details
- Accession Number:
- 0001125345-19-000083
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-22 16:21:32
- Reporting Period:
- 2019-05-20
- Accepted Time:
- 2019-05-22 16:21:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1125345 | Macrogenics Inc | MGNX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1587774 | Blasius Eric Risser | 9704 Medical Center Drive Rockville MD 20850 | Sr Vp & Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-20 | 3,000 | $0.94 | 33,806 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-20 | 3,000 | $18.38 | 30,806 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-22 | 1,000 | $0.94 | 31,806 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-22 | 1,000 | $19.03 | 30,806 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee stock option (right to buy) | Disposition | 2019-05-20 | 3,000 | $0.00 | 3,000 | $0.94 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-05-22 | 1,000 | $0.00 | 1,000 | $0.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,653 | 2012-09-14 | 2022-03-13 | No | 4 | M | Direct |
| 1,662 | 2010-07-10 | 2020-01-09 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2019.
- The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $18.25 to $18.50. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $19.00 to $19.026. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
Billionaire Hedge Funds
